Effects of post-treatment with direct hemoperfusion using a CTR column on mortality and inflammatory responses to endotoxin-induced shock in rats

Blood Purification

Volumn 24, Issue 5-6, 2006, Pages 460-464

  Taniguchi, Takumi ^a   Takemoto, Yasuhiro ^a   Tsuda, Kazunobu ^a   Inaba, Hideo ^a   Yamamoto, Ken ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cytokine; Endotoxin; Hemoperfusion; Sepsis

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; ENDOTOXEMIA; ESCHERICHIA COLI; HEMODYNAMICS; HEMOPERFUSION; INFLAMMATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GAS ANALYSIS; ENDOTOXINS; HEMOPERFUSION; HYPOTENSION; INTERLEUKIN-6; MALE; RATS; RATS, WISTAR; SHOCK; TIME FACTORS;

EID: 33845916327     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095554     Document Type: Article

References (10)

1. Wakabayashi G, Gelfard JA, Jung WK, et al: Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock like state and tissue injury in rabbits without endotoxemia: comparison to Escherichia coli. J Clin Invest 1991;87:1925-1935.
2. Casey LC, Balk RA, Bone RC: Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-778.
3. Marty C, Misset B, Tamion F, et al: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-679.
4. Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in human. J Infect Dis 1995;171:145-152.
5. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989;17:975-978.
6. Natanson C, Eichenholz PW, Danner RL, et al: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823-832.
7. Taniguchi T, Hirai F, Takemoto Y, et al: A novel adsorbent of circulating bacterial toxins and cytokines; the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia. Crit Care Med 2006;34:800-806.
8. Taniguchi T, Yamamoto K, Ohmoto N, et al: Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000;28:1101-1106.
9. Taniguchi T, Shibata K and Yamamoto K: Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 2001;95:928-932.
10. Debets JMH, Kampmeijer R, van der Linden MPMH, et al: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989;17:489-494.